N. Bodick

2.5k citations

42 papers · 1.9k indexed · 1 hit paper · h-index 22

Impact in

Rheumatology top 2%
- Osteoarthritis Treatment and Mechanisms
Cellular and Molecular Neuroscience top 5%
- Neuroscience and Neuropharmacology Research

Papers in ⓘ

Rheumatology 17
- Osteoarthritis Treatment and Mechanisms 17
Pharmacology 15
- Inflammatory mediators and NSAID effects 10

Co-authors: Walter Offen (7 shared papers)Andrew Satlin (4 shared papers)H E Shannon (2 shared papers)Joelle Lufkin (11 shared papers)Serge Gauthier (3 shared papers)Philip G. Conaghan (7 shared papers)Frank P. Bymaster (3 shared papers)Cyrus Levinthal (1 shared paper)
Journals: Osteoarthritis and Cartilage (12 papers)Neurobiology of Aging (3 papers)Developmental Brain Research (2 papers)Journal of Bone and Joint Surgery (2 papers)European Neuropsychopharmacology (2 papers)
Partner nations: United States United Kingdom Canada

In The Last Decade

N. Bodick

42 papers receiving 1.9k citations

Hit Papers

align trajectories log scale

Effects of Xanomeline, a Selective Muscarinic Receptor Agonist, on Cognitive Function and Behavioral Symptoms in Alzheimer Disease 1997 · 528 citations

Peers

Countries citing papers authored by N. Bodick

Since Specialization

Citations

This map shows the geographic impact of N. Bodick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Bodick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Bodick more than expected).

Fields of papers citing papers by N. Bodick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Bodick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Bodick. The network helps show where N. Bodick may publish in the future.

Co-authors

The 25 scholars most cited alongside N. Bodick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with N. Bodick Line = papers co-authored together N. Bodick links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Effects of Xanomeline, a Selective Muscarinic Receptor Agonist, on Cognitive Function and Behavioral Symptoms in Alzheimer Disease Archives of Neurology ·N. Bodick, Walter Offen, Allan I. Levey, N.R. Cutler, Serge Gauthier, Andrew Satlin, H E Shannon, Gary D. Tollefson, K. Rasmussen, Frank P. Bymaster, David J. Hurley, William Z. Potter, Steven M. Paul Hit paper breakdown →	1997	528
2	Effects of a Single Intra-Articular Injection of a Microsphere Formulation of Triamcinolone Acetonide on Knee Osteoarthritis Pain Journal of Bone and Joint Surgery ·Philip G. Conaghan, David J. Hunter, Stanley Cohen, Virginia B. Kraus, Francis Bérenbaum, Jay R. Lieberman, Deryk G. Jones, Andrew I. Spitzer, David S. Jevsevar, Nathaniel P. Katz, Diane J. Burgess, Joelle Lufkin, James R. Johnson, N. Bodick	2018	136
3	Synovial and systemic pharmacokinetics (PK) of triamcinolone acetonide (TA) following intra-articular (IA) injection of an extended-release microsphere-based formulation (FX006) or standard crystalline suspension in patients with knee osteoarthritis (OA) Osteoarthritis and Cartilage ·Virginia B. Kraus, Philip G. Conaghan, H.A. Aazami, P. Mehra, Alan Kivitz, Joelle Lufkin, J. Hauben, James R. Johnson, N. Bodick	2017	107
4	An Intra-Articular, Extended-Release Formulation of Triamcinolone Acetonide Prolongs and Amplifies Analgesic Effect in Patients with Osteoarthritis of the Knee Journal of Bone and Joint Surgery ·N. Bodick, Joelle Lufkin, C. Willwerth, Anjali S. Kumar, James A. Bolognese, C. Schoonmaker, Rahul Ballal, David J. Hunter, Michael D. Clayman	2015	98
5	The selective muscarinic agonist xanomeline improves both the cognitive deficits and behavioral symptoms of Alzheimer disease. PubMed ·N. Bodick, Walter Offen, H E Shannon, Julie Satterwhite, Ruth Lucas, Rob van Lier, Steven Paul	1997	89
6	Xanomeline: A selective muscarinic agonist for the treatment of Alzheimer's disease Drug Development Research ·Frank P. Bymaster, Celia A. Whitesitt, Harlan E. Shannon, Neil W. DeLapp, John S. Ward, David O. Calligaro, Lisa A. Shipley, J Buelke-Sam, N. Bodick, Lars Farde, Malcolm J. Sheardown, Preben H. Olesen, Kristian T. Hansen, Peter D. Suzdak, Michael D.B. Swedberg, Per Sauerberg, Charles H. Mitch	1997	89
7	Growing optic nerve fibers follow neighbors during embryogenesis. Proceedings of the National Academy of Sciences ·N. Bodick, Cyrus Levinthal	1980	84
8	Machine-learning, MRI bone shape and important clinical outcomes in osteoarthritis: data from the Osteoarthritis Initiative Annals of the Rheumatic Diseases ·M.A. Bowes, Katherine Kacena, Oras Alabas, Alan Brett, B. Dube, N. Bodick, Philip G. Conaghan	2020	80
9	Brief Report: A Phase IIb Trial of a Novel Extended‐Release Microsphere Formulation of Triamcinolone Acetonide for Intraarticular Injection in Knee Osteoarthritis Arthritis & Rheumatology ·Philip G. Conaghan, Stanley Cohen, Francis Bérenbaum, Joelle Lufkin, James R. Johnson, N. Bodick	2017	70
10	Sustained efficacy of a single intra-articular dose of FX006 in a rat model of repeated localized knee arthritis Osteoarthritis and Cartilage ·Anjali S. Kumar, A.M. Bendele, R.C. Blanks, N. Bodick	2014	66
11	Quality-of-life assessment in dementia drug development. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. PubMed ·Peter J. Whitehouse, J. M. Orgogozo, Robert E. Becker, Serge Gauthier, Michael J. Pontecorvo, H. Erzigkeit, Sharon Rogers, Richard C. Mohs, N. Bodick, Giuseppe Bruno, Peter Dal‐Bianco	1997	65
12	Brain proton magnetic resonance spectroscopy (1H-MRS) in Alzheimer's disease: changes after treatment with xanomeline, an M1 selective cholinergic agonist American Journal of Psychiatry ·Andrew Satlin, N. Bodick, Walter Offen, Perry F. Renshaw	1997	63
13	A more rational approach to new-product development. PubMed ·Eric Bonabeau, N. Bodick, Robert W. Armstrong	2008	52
14	Serial reconstruction of microtubular arrays within dendrites of the cat retinal ganglion cell: The cytoskeleton of a vertebrate dendrite Brain Research ·Sharon E. Sasaki, John K. Stevens, N. Bodick	1983	48
15	Efficacy of Xanomeline in Alzheimer Disease: Cognitive Improvement Measured Using the Computerized Neuropsychological Test Battery (CNTB) Alzheimer Disease & Associated Disorders ·Amy E. Veroff, N. Bodick, Walter W. Offen, John J. Sramek, Neal R. Cutler	1998	47
16	Microtubule disarray in cortical dendrites and neurobehavioral failure. I. Golgi and electron microscopic studies Developmental Brain Research ·Dominick P. Purpura, N. Bodick, Kotaro Suzuki, I. Rapin, Sarah Wurzelmann	1982	38
17	Objective psychometric tests in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. PubMed ·Steven H. Ferris, Ugo Lucca, Richard C. Mohs, B. Dubois, Keith Wesnes, H. Erzigkeit, David Geldmacher, N. Bodick	1997	37
18	Brain Proton Magnetic Resonance Spectroscopy in Alzheimer Disease: Changes After Treatment With Xanomeline American Journal of Geriatric Psychiatry ·Blaise deB. Frederick, Andrew Satlin, Lawrence L. Wald, John Hennen, N. Bodick, Perry F. Renshaw	2002	33
19	Triamcinolone acetonide extended-release in patients with osteoarthritis and type 2 diabetes: a randomized, phase 2 study Lara D. Veeken ·Steven J. Russell, Robert D. Sala, Philip G. Conaghan, George Habib, Quang Vo, Rickey Manning, Alan Kivitz, Yvonne Davis, Joelle Lufkin, James R. Johnson, Scott D. Kelley, N. Bodick	2018	29
20	Protocols to demonstrate slowing of Alzheimer disease progression. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. The Disease Progression Sub-Group. PubMed ·N. Bodick, F. Forette, D. Hadler, Richard Harvey, Paul Leber, Ian G. McKeith, Paavo Riekkinen, Martin N. Rossor, Philip Scheltens, Shun Shimohama, René Spiegel, S. Tanaka, L. J. Thal, Y. Urata, Peter J. Whitehouse, Gordon Wilcock	1997	28

About N. Bodick

N. Bodick is a scholar working on Rheumatology, Pharmacology, Molecular Biology, Surgery and Cellular and Molecular Neuroscience, having authored 42 papers that have together received 1.9k indexed citations. Recurring topics across this work include Osteoarthritis Treatment and Mechanisms (17 papers), Inflammatory mediators and NSAID effects (10 papers), Tendon Structure and Treatment (5 papers), Cancer Treatment and Pharmacology (3 papers), Analytical Methods in Pharmaceuticals (3 papers), Metabolomics and Mass Spectrometry Studies (3 papers), Advanced MRI Techniques and Applications (3 papers) and Dementia and Cognitive Impairment Research (3 papers). The work is most often cited by research in Rheumatology (508 citations), Cellular and Molecular Neuroscience (582 citations), Pharmacology (412 citations), Psychiatry and Mental health (278 citations) and Biological Psychiatry (44 citations). N. Bodick has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Walter Offen, Andrew Satlin, H E Shannon, Joelle Lufkin, Serge Gauthier, Philip G. Conaghan, Frank P. Bymaster, Cyrus Levinthal, Allan I. Levey and William Z. Potter. Their work appears in journals such as Osteoarthritis and Cartilage, Neurobiology of Aging, Developmental Brain Research, Journal of Bone and Joint Surgery and European Neuropsychopharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact